Reader Picks: 2016’s Top Stories

The ACR workforce study, options for methotrexate, safe doses for glucocorticoids, the value of vitamin D supplements, the dangers of chikungunya, and new treatments for giant cell arteritis were among our most popular stories this year. Here's a quick look back at 2016.

Related Videos

Related Content

Advertisement

December 23rd 2024

Study Highlights 5-Year Real-World Survival of Dupilumab for Atopic Dermatitis

Tim Smith

December 23rd 2024

Navigating Lifestyle and Pharmacotherapy Interventions in Dyslipidemia Management

Pam R. Taub, MD, FACC, FASPC Marc P. Bonaca, MD, MPH

December 23rd 2024

Use of Ibuprofen, Other NSAIDs During Pregnancy Could Increase Risk of Childhood CKD

Abigail Brooks, MA

December 17th 2024

Video: Exploring Bempedoic Acid: Clinical Indications, Efficacy, and Future Directions in Cardiovascular Risk Management

Pam R. Taub, MD, FACC, FASPC Marc P. Bonaca, MD, MPH

December 23rd 2024

FDA Approves Concizumab for Hemophilia A or B with Inhibitors

Connor Iapoce

December 23rd 2024

Hyperglycemia, Obesity Relevant Risk Factors for Retinopathy in Type 1 Diabetes

Connor Iapoce

Related Content

Advertisement

December 23rd 2024

Study Highlights 5-Year Real-World Survival of Dupilumab for Atopic Dermatitis

Tim Smith

December 23rd 2024

Navigating Lifestyle and Pharmacotherapy Interventions in Dyslipidemia Management

Pam R. Taub, MD, FACC, FASPC Marc P. Bonaca, MD, MPH

December 23rd 2024

Use of Ibuprofen, Other NSAIDs During Pregnancy Could Increase Risk of Childhood CKD

Abigail Brooks, MA

December 17th 2024

Video: Exploring Bempedoic Acid: Clinical Indications, Efficacy, and Future Directions in Cardiovascular Risk Management

Pam R. Taub, MD, FACC, FASPC Marc P. Bonaca, MD, MPH

December 23rd 2024

FDA Approves Concizumab for Hemophilia A or B with Inhibitors

Connor Iapoce

December 23rd 2024

Hyperglycemia, Obesity Relevant Risk Factors for Retinopathy in Type 1 Diabetes

Connor Iapoce